Potential applications for comprehensive cancer cell analysis


  • Early detection of local or metastatic disease
  • Prognostic tool
  • Support best treatment choice on an individualized basis
  • Monitor the post-treatment reduction in the number of cancer cells as a response to therapy


  • Monitor response in preclinical research to novel anticancer drug in development
  • Monitor response in clinical trials of novel anticancer therapy


  • Basic and translational research
the product
Liquid Biopsy AB has developed a technology that can isolate cancer cells for liquid-based cytology and Circulating Tumor Cells that can support diagnosis, choice and monitoring of treatment, and drug development.